NTRK1 and carcinoma: Immunohistochemistry experiments demonstrated that the cytoplasmic/perinuclear positivity of the LMNA::TRKA fusion protein in a variety of tumor types, including carcinoma and sarcoma, is an effective diagnostic tool [14, 15].